Geoffrey M. Duyk, Director at AERIE PHARMACEUTICALS INC (AERI), sold 99,758 shares at $46.46 ($4.7M) on 2017-02-14, disclosed to the SEC on 2017-02-16.
Open-market sale of $4.7M AERI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.46 | 20,795 | $966K | 20.7% |
| 2 | $46.46 | 20,795 | $966K | 20.7% |
| 3 | $46.95 | 5,047 | $237K | 5.1% |
| 4 | $46.95 | 6,880 | $323K | 6.9% |
| 5 | $46.95 | 1,879 | $88K | 1.9% |
| 6 | $46.95 | 2,770 |
| $130K |
| 2.8% |
| 7 | $46.81 | 20,796 | $973K | 20.9% |
| 8 | $46.81 | 20,796 | $973K | 20.9% |
| Total | $46.69 avg | 99,758 | $4.7M | 100% |